PeptidePedia The community reference

Qingdao Sigma Chemical (revision 24)

Old revision·17:29, 31 Dec 2025·DeadSpaceDot

This is an old revision of this page, as it stood at 17:29, 31 Dec 2025, saved by DeadSpaceDot with the summary fix indentation in the source. It may differ substantially from the current revision, and any error it contains may since have been corrected.
This article is about the organisation. For the general subject, see Peptide supply chain; for the criteria under which supplier articles exist here, see Project:Vendor notability.
This article relies excessively on primary sources. (July 2026) Discussion: Attributed founding year versus registry record.
Qingdao Sigma Chemical Co., Ltd.Organisation
representative synthesis and QC site (schematic)
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.
Legal nameQingdao Sigma Chemical Co., Ltd.
Trading nameQSC
Other designationsSigma Chemical, QSC Peptides
Identity
FoundedReported 2017 (not registry-verified)
HeadquartersQingdao, Shandong, China
IndustryResearch-compound supply
Official siteVisit QSC at qingdaosigma.com
Products and documentation
Product scoperesearch peptides and raw materials
Catalogue sizeNot documented
DocumentationBatch certificate of analysis reported with orders
Independent reportsSubmitted to this wiki by purchasers; see §Independent testing record
PeptidePedia reception tally
Submissions571 to July 2026
Evidence qualityWeak — self-selected, self-reported
Organisation infobox · conventions

Qingdao Sigma Chemical Co., Ltd. (trading as QSC; qingdaosigma.com) is a research-peptide supplier based in Qingdao, Shandong, China, described in available sources as operating from 2017 and distributing research peptides through a warehouse network, with third-party testing reported on part of its range.[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]

Corporate identity and history

[edit]

Available sources describe the organisation as having begun operations in 2017 in Qingdao, Shandong.[2] No registry record has been verified by this wiki and no primary trading domain is documented, so the founding year is attributed rather than asserted — a distinction that matters because every other date in this group of articles rests on a registry record.[1]

The organisation is described as operating a distributed warehouse network rather than shipping solely from China. Where that arrangement exists it changes the cold-chain and customs profile of an order substantially, and purchaser reports have described both domestic-origin and China-origin shipments.[5]

Distribution and dispatch

[edit]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Operations and documentation practice

[edit]

Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance.[5] Water figures and method statements are issued against a named lot on request, so a purchaser who needs a purity figure convertible into a mass should ask for the content and water determinations at the point of order rather than after dispatch.[6]

Reports on shipments from regional warehouses describe shorter transit and no customs interaction; reports on China-origin shipments describe the conventional pattern. The organisation states which origin will be used at the point of order, and a purchaser who wants to know the certificate-to-dispatch interval for a warehouse item can ask for it against the lot number.[5]

Product range

[edit]
ClassRepresentative listingsDocumentation reported
Incretin analoguesSemaglutide, tirzepatideCertificate with purity and appearance; water on request
Research peptidesRepair and secretagogue peptidesCertificate with purity; water and method on request
Raw materialsBulkCertificate with identity and purity; specification sheet on request

The catalogue is short and stock-led rather than quotation-led: the listings above are the lines held in the regional warehouses, which is what produces the dispatch windows recorded in §Ordering and availability.[5] Water and method determinations are issued against a named lot on request for any line in the table.

Independent testing record

[edit]

Third-party reports on QSC material have been submitted to this wiki across a moderate range of analytes.[5] Reported area percent figures have sat in the high nineties across the incretin lines, and reports on warehouse-dispatched and China-dispatched material have not differed from one another in any respect the submitted set can resolve.

Dispersion within any purchaser-submitted set is a property of the reports before it is a property of the material, and the interpretation is limited by self-selection everywhere on this wiki.[5] The determination that removes most of the remaining ambiguity is the method statement: with the gradient, column chemistry and detection wavelength on the page, a difference between a certificate and an independent report can be attributed to the separation rather than left open. It is issued against a named lot on request, alongside the water figure, and §Ordering and availability sets out what to quote when asking.[6]

Ordering and availability

[edit]
The organisation publishes its own catalogue and current stock at qingdaosigma.com. Visit QSC →

Catalogue lines dispatch either from held regional stock or from China, and which applies to a given line is stated at the point of order; submissions describe the regional route as materially faster.[5]

Minimum order quantity is one vial on catalogue lines. Bulk enquiries are quoted separately and are the part of the operation submissions describe most often.

The certificate names the lot and the release date and reports purity and appearance; water and method statements are issued against a named lot on request.[6]

To obtain the batch record, quote the lot identifier, ask which origin the order shipped from, and request the water determination and the analytical conditions. Knowing the origin matters because it fixes the interval between the certificate date and the dispatch date.

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

Material described here is labelled for research use only and is not approved for human use in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them.

Go to the QSC catalogue →

Reception

[edit]

The PeptidePedia tally records 571 self-reported submissions to July 2026. Recurring themes are dispatch speed where a regional warehouse was used and the handling of bulk enquiries.[4] The count is smaller than for most articles in this group, which reflects how many purchasers chose to submit rather than anything about the organisation; the tally is self-selected and measures reception rather than quality.[4]

How this tally should be read

[edit]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

  • Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
  • It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
  • It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.[4]

[edit]

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.[3]

Notability and coverage

[edit]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,[7] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

The article's talk page carries the notability assessment in full, together with the drafting decisions that follow from it: what this article may state outright, what it may only attribute, and what it must leave out.

[edit]

See also

References

  1. ^ a b c d National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
  2. ^ a b c d Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
  3. ^ a b c Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
  4. ^ a b c d e PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
  5. ^ a b c d e f g h Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
  6. ^ a b c d United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.
  7. ^ World Health Organization, Good Manufacturing Practices for Pharmaceutical Products: Main Principles, WHO Technical Report Series. The general framework against which a GMP claim is assessed.
  8. ^ ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories. International Organization for Standardization.

Further reading